Nucleic acid preservation solution and methods of manufacture and use
Abstract
Disclosed is nucleic acid preserving compositions and methods of manufacturing and using the same. Compositions include a carrier, a chaotropic agent, a buffering agent, a chelating agent, a surfactant, an alcohol, an acid, and a mucolytic agent. Compositions as aqueous solutions can include water as a carrier. Preferred embodiments include water, guanidine thiocyanate, Tris, EDTA, SLS, SDA 3C, HCl, and N-acetyl-L-cysteine. Some embodiments include a colored dye as a visual indicator. Methods of manufacturing include combining the components into a mixture, such as an aqueous solution. Methods of use include providing a biological sample that includes nucleic acid and contacting the biological sample with the composition. Kits include the composition disposed in a portion of a biological sample collection apparatus.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A nucleic acid preservation composition, comprising:
an aqueous carrier; about 20% to about 50%, w/w, of a chaotropic agent; about 0.1% to about 5%, w/w, of a buffering agent; about 0.05% to about 2.5%, w/w, of a chelating agent comprising; about 0.01% to about 5%, w/w, of a detergent or a surfactant; about 5% to about 25%, w/w, of an alcohol, wherein the alcohol comprises ethanol and optionally comprises isopropanol; and 0.005% to about 0.5%, w/w, of a mucolytic agent or a reducing agent, wherein the mucolytic agent or reducing agent is other than dithiothreitol and/or 2-mercaptoethanol, the composition having a pH of 6.5-9.5.
2 . The composition of claim 1 , wherein the composition has a pH of about 7 to about 9.
3 . The composition of claim 1 , wherein:
the chaotropic agent comprises guanidine thiocyanate; the buffering agent comprises tris(hydroxymethyl)aminomethane (Tris); the chelating agent comprises ethylenediaminetetraacetic acid (EDTA) or EDTA disodium (salt) dihydrate; and the detergent or surfactant comprises sodium lauroyl sarcosinate (SLS).
4 . The composition of claim 1 , wherein the composition is substantially free or devoid of antimicrobial agent(s), bactericidal agent(s), and/or bacteriostatic agent(s) other than the chaotropic agent, the detergent or surfactant, the alcohol, and the mucolytic agent or reducing agent.
5 . The composition of claim 1 , wherein the composition is substantially free or devoid of protease(s).
6 . The composition of claim 1 , wherein the composition is substantially free or devoid of inhibitor(s) of ribonuclease other than the chaotropic agent, the surfactant, the alcohol, and the mucolytic agent.
7 . A nucleic acid preservation kit, comprising:
a sample collection apparatus comprising a solution compartment; and the nucleic acid preservation composition of claim 1 disposed in the solution compartment.
8 . A method of preserving nucleic acid in a biological sample, the method comprising:
obtaining or providing a biological sample containing nucleic acid, the biological sample optionally comprising saliva; and contacting the biological sample with the nucleic acid preservation composition of claim 1 .
9 . A nucleic acid preservation composition, comprising:
guanidine thiocyanate; tris(hydroxymethyl)aminomethane (Tris); ethylenediaminetetraacetic acid (EDTA) or EDTA disodium (salt) dihydrate; sodium lauroyl sarcosinate (SLS); an alcohol, wherein the alcohol comprises ethanol and optionally comprises isopropanol; and a mucolytic agent or reducing agent other than dithiothreitol and/or 2-mercaptoethanol.
10 . The composition of claim 9 , wherein the composition has a pH of 6.5-9.5.
11 . The composition of claim 9 , wherein the composition has a pH of 7-9.
12 . The composition of claim 9 , wherein the composition is substantially free or devoid of antimicrobial agent(s), bactericidal agent(s), and/or bacteriostatic agent(s) other than the chaotropic agent, the detergent or surfactant, the alcohol, and the mucolytic agent or reducing agent.
13 . The composition of claim 9 , wherein the composition is substantially free or devoid of protease(s).
14 . The composition of claim 9 , wherein the composition is substantially free or devoid of inhibitor(s) of ribonuclease other than the chaotropic agent, the surfactant, the alcohol, and the mucolytic agent.
15 . A nucleic acid preservation kit, comprising:
a sample collection apparatus comprising a solution compartment; and the nucleic acid preservation composition of claim 9 disposed in the solution compartment.
16 . A method of preserving nucleic acid in a biological sample, the method comprising:
obtaining or providing a biological sample containing nucleic acid, the biological sample optionally comprising saliva; and contacting the biological sample with the nucleic acid preservation composition of claim.
17 . A nucleic acid preservation composition, comprising:
an aqueous carrier; a chaotropic agent; a buffering agent; a chelating agent; a detergent or a surfactant; an alcohol, wherein the alcohol comprises ethanol and optionally comprises isopropanol; and a mucolytic agent or reducing agent other than dithiothreitol and/or 2-mercaptoethanol.
18 . The nucleic acid preservation composition of claim 17 , wherein the composition has a pH of about 7 to about 9.
19 . The nucleic acid preservation composition of claim 18 , wherein:
the composition is substantially free or devoid of antimicrobial agent(s), bactericidal agent(s), and/or bacteriostatic agent(s) other than the chaotropic agent, the detergent or surfactant, the alcohol, and the mucolytic agent or reducing agent; the composition is substantially free or devoid of protease(s); and the composition is substantially free or devoid of inhibitor(s) of ribonuclease other than the chaotropic agent, the surfactant, the alcohol, and the mucolytic agent.
20 . The nucleic acid preservation composition of claim 19 , wherein:
the chaotropic agent comprises guanidine thiocyanate; the buffering agent comprises tris(hydroxymethyl)aminomethane (Tris); the chelating agent comprises ethylenediaminetetraacetic acid (EDTA) or EDTA disodium (salt) dihydrate; and the detergent or surfactant comprises sodium lauroyl sarcosinate (SLS).Join the waitlist — get patent alerts
Track US2023304071A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.